BioLife Solutions, Inc.BLFSNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank71
3Y CAGR-20.0%
5Y CAGR+2.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-20.0%/yr
vs +83.8%/yr prior
5Y CAGR
+2.4%/yr
Recent deceleration
Acceleration
-103.8pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
2025$7.57M-4.4%
2024$7.91M-57.9%
2023$18.80M+27.0%
2022$14.80M+25.2%
2021$11.82M+75.9%
2020$6.72M+63.1%
2019$4.12M+217.4%
2018$1.30M+8.8%
2017$1.19M-41.2%
2016$2.03M-